Latigo Biotherapeutics
PrivateLast Round
Series B
Mar 17, 2025
Total Funding Raised
$285M
Company Overview
Latigo Bio is a biotechnology company focused on developing innovative non-opioid therapies for chronic pain management, utilizing a unique platform that targets therapeutics across the blood-nerve barrier to ensure safe and effective treatment options for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Latigo Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Latigo Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2025 | ||||
| Series A | Feb 14, 2024 |
Latigo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village Biopartners | Series B, Series A |
| Corner Ventures | Series A |
| Blue Owl Capital | Series B |
| Deep Track Capital | Series B |
| 5AM Ventures | Series B, Series A |
| Foresite Capital | Series B, Series A |
| Alexandria Venture Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Advancing non-opioid pain therapies with a Phase 3 asset.
- Mar 3, 2026
Neha Krishnamohan appointed as CFO and CBO.
Latigo Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Latigo Biotherapeutics's valuation, stock price, and market status.
